Related Experiment Video
Updated: Jan 1, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.9K
Clinical implementation in proton therapy of multi-field optimization by a hybrid method combining conventional PTV
Francesco Tommasino1,2,3, Lamberto Widesott4, Francesco Fracchiolla4
1Department of Physics, University of Trento, Via Sommarive, 14-38123 Povo (TN), Italy.
Physics in Medicine and Biology
|December 19, 2019
Summary
A new hybrid multi-field optimization (hMFO) technique improves proton therapy planning by enhancing organ at risk sparing compared to single-field optimization. This robust method is as effective as full robust multi-field optimization, making Monte Carlo-based robust optimization clinically feasible.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Biology
Background:
- Robust optimization is crucial in proton therapy to account for uncertainties.
- Monte Carlo (MC) algorithms offer high accuracy but are computationally intensive for robust optimization.
- Existing multi-field optimization (MFO) techniques can be complex and time-consuming.
Purpose of the Study:
- To implement and evaluate a novel hybrid multi-field optimization (hMFO) technique for robust proton therapy planning.
- To assess the compatibility of hMFO with Monte Carlo (MC) algorithms.
- To compare the robustness and plan quality of hMFO against single-field optimization (SFO) and full robust multi-field optimization (fMFO).
Main Methods:
- A hybrid robust multi-field optimization (hMFO) approach was developed, incorporating setup errors into the planning target volume (PTV) and range uncertainties into the PTV robust optimization.
- Proton therapy plans were generated for nine patients using hMFO, SFO, and fMFO.
- Plans were compared based on organ at risk (OAR) sparing and robustness to physical uncertainties and variable relative biological effectiveness (RBE).
Main Results:
- hMFO significantly reduced the number of scenarios for robust optimization compared to fMFO (3 vs. 21), enabling MC-based application.
- Normalized hMFO plans showed superior OAR sparing compared to SFO (p < 0.01) with no significant difference from fMFO.
- hMFO demonstrated robustness comparable to fMFO in worst-case scenarios and was unaffected by variable RBE.
Conclusions:
- hMFO provides a clinically feasible approach for robust optimization in proton therapy using MC algorithms.
- The technique improves plan quality over SFO without compromising robustness to setup, range, or RBE uncertainties.
- hMFO offers a practical balance between computational efficiency and plan robustness.

